-
How Is Abbott Laboratories' Stock Performance Compared to Other Medical Devices Stocks?
02 Sep 2025 22:32 GMT
North Chicago, Illinois-based Abbott Laboratories (ABT) develops, manufactures, and markets … , including medical devices, diagnostics, branded generic pharmaceuticals, and nutritional products. Valued …
-
Global Telmisartan Market Surges with Rising Hypertension Cases and Expanding Generic Drug Adoption by 2031
29 Aug 2025 12:30 GMT
… Patent expirations are encouraging generic competition and price optimization … and form strategic partnerships.
Abbott Laboratories
Aurobindo Pharmaceuticals
Boehringer Ingelheim … Companies investing in affordable generics, digital healthcare solutions, …
-
Abbott Laboratories (NYSE:ABT) Q2 2025 Earnings Call Transcript
19 Jul 2025 12:45 GMT
… areas of growth for branded generic medicines. The growth in these … a broad portfolio of branded generic medicines tailored to local conditions … a wonderful day.
Follow Abbott Laboratories (NYSE:ABT) Follow Abbott Laboratories (NYSE:ABT) We …
-
Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'
18 Jul 2025 01:32 GMT
… devices, diagnostics, nutritional products and generic pharmaceuticals. The company is currently … also said Abbott's generic pharmaceutical business is doing well … Investing Club holds shares of Abbott Laboratories.
Questions for Cramer?
Call Cramer …
-
Oppenheimer Reiterates ‘Outperform’ Rating on Abbott Laboratories (ABT)
11 Jul 2025 00:33 GMT
… Reiterates ‘Outperform’ Rating on Abbott Laboratories (ABT) A close up of … requirements for tricuspid regurgitation severity. Abbott Laboratories (NYSE:ABT) is a … defensive stocks, as it provides generic pharmaceuticals, laboratory, and transfusion …
-
What to Expect From Abbott Laboratories' Q2 2025 Earnings Report
01 Jul 2025 19:22 GMT
… cap of $233.8 billion, Abbott Laboratories (ABT) is a global healthcare … , medical devices, nutritionals, and branded generics in emerging markets. Abbott has … divestitures, including its developed markets generics and vision care businesses. The …
-
United States Generic Drugs Market Forecast and Company Analysis Report 2025-2033 Featuring Teva Pharma, Aurobindo Pharma, Sun Pharma, Abbott Laboratories, Lupin Pharma, Viatris, Sandoz, Dr. Reddy's - ResearchAndMarkets.com
19 May 2025 16:43 GMT
… Pharmaceuticals
Aurobindo Pharma
Sun Pharmaceuticals
Abbott Laboratories Inc
Lupin Pharmaceuticals, Inc
Viatris … What are Generic Drugs?
1.2 Unbranded and Branded Generics
1.3 … Generics
1.4 Commoditized and Specialty Generics
2. Why is the US Generic …
-
Generic Pharmaceuticals Market Opportunities and Strategy Report 2024-2033 Featuring Key Players - Teva Pharmaceutical, Sandoz, Sun Pharmaceutical, Viatris, and Abbott Laboratories - ResearchAndMarkets.com
09 May 2025 15:46 GMT
… by type into biosimilars and generics. The generic market was the largest … Markets Covered:
By Type: Biosimilars; Generics
By Therapy: Oncology Drugs; Central … Pharmaceutical Industries Ltd.
Viatris Inc.
Abbott Laboratories
Other Companies Featured
Dr. Reddy …
-
Dividend Stock Analysis: Abbott Laboratories
18 Apr 2025 16:18 GMT
… a detailed quantitative analysis of Abbott Laboratories (ABT). Below are some … focused on nutritionals, diagnostics, generic drugs, and medical devices, … products. Its products include branded generic pharmaceuticals manufactured internationally, marketed …
-
Abbott Laboratories's Earnings Outlook
15 Apr 2025 14:22 GMT
… explores the latest insights regarding Abbott Laboratories.
Abbott Laboratories has received a total of … and testing kits, and branded generic drugs. Products include pacemakers, implantable …